Learn more about Merz Therapeutics
Learn about us
United States
Patient Advocacy
Merz Therapeutics is a trusted and authentic partner to the movement disorders and neurological conditions community.
We embed lived experience into our culture and decision-making, build transparent partnerships, advance access and equity and shape solutions that strengthen patient outcomes.
Merz Therapeutics’ nurse-led Patient Support Program for Parkinson’s Disease now guides patients through their treatment journey and addresses individual needs.
Starting at the point of medication delivery, the program reduces barriers and improves outcomes through personalized education, behavioral coaching and multi-channel engagement.
The program follows a Care-Centered Clinical Education framework:
Patients receive a welcome call with their first shipment, followed by scheduled adherence check-ins at days 14, 28 and 90. Additional follow-ups are offered based on individual needs to ensure timely support and sustained adherence.
Support is delivered via phone or virtual sessions, at times convenient for the patient. Nurses may involve caregivers (with consent) and use translation services as needed.
Merz Connect® is a one-stop platform to help people navigate treatment with confidence. From product access support to reimbursement services, Merz Connect® connects patients, caregivers and healthcare providers with the information and assistance they may need along the treatment journey.
For individuals who qualify, Merz Therapeutics’ Patient Assistance Program provides XEOMIN® (incobotulinumtoxinA) at no cost. This program is designed to support patients who may face financial or insurance-related barriers to treatment, helping ensure that access to care is based on need, not circumstance.
The Dystonia Medical Research Foundation (DMRF) is dedicated to serving all people with dystonia and their families by advancing research for more treatments and ultimately a cure, as well as promoting awareness and education.
The Dystonia Medical Research Foundation (DMRF) in Canada works in partnership with the DMRF in the U.S. to ensure funding of the best and most relevant dystonia medical research worldwide and partners with other like-minded research organizations to fund excellent dystonia research in Canada.
Dyfying Dystonia is a dystonia awareness campaign launched by Casey Kidson under the Dystonia Medical Research Foundation (DMRF) in Canada, aiming to support DMRF Canada with their goals of advancing research in hopes of finding a cure.
The National Multiple Sclerosis Society is the largest multiple sclerosis organization in the world. They fund research to reach MS cures and connect affected individuals to educational resources, healthcare professionals and support groups.
The Multiple Sclerosis Society of Canada works with researchers, donors, partners, volunteers and people living with MS to bring about positive change, improving the lives of Canadians today and supporting high-quality research that aims to end MS tomorrow.
The Cerebral Palsy Alliance Research Foundation (CPARF) funds U.S.-based research on cerebral palsy, implements proven science, empowers people through education and advances technology benefiting all disabled people worldwide.
You are leaving this website. With respect to the content of the following page, as well as to links to other websites located on this page, Merz Therapeutics U.S. has no way of controlling the content of these sites. Merz Therapeutics U.S. assumes no responsibility for the content of these sites or the consequences of their use by visitors. However, we ask you to notify us immediately of any illegal content on the linked sites.
You are leaving this website. The content of the following sites maintained by the parent company or another affiliated company, or links to other sites located on this site, is subject to the legal requirements of the country in which the site is maintained. Merz Therapeutics U.S. accepts no responsibility whatsoever for the content of these websites or for the consequences of their use by visitors. However, we ask you to notify us immediately of any illegal content on the linked sites.